Pasar al contenido principal

MECANISMOS MOLECULARES Y CELULARES DE LOS RECEPTORES NUCLEARES EN EL CONTROL DEL METABOLISMO Y DE LAS RESPUESTAS INMUNITARIAS

PID2020-119875RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation

  • Hernández-Hernández, Irene
  • De La Rosa, Juan V.
  • Martín-Rodríguez, Patricia
  • Díaz-Sarmiento, Mercedes
  • Recio, Carlota
  • Guerra, Borja
  • Fernández-Pérez, Leandro
  • León, Theresa E.
  • Torres Blanch, Rosa|||0000-0002-9109-4035
  • Font-Díaz, Joan|||0000-0002-7686-2278
  • Roig, Angela
  • Mora Pérez, Fernando de|||0000-0002-3002-6004
  • Boscá, Lisardo|||0000-0002-0253-5469
  • Díaz, Mario
  • Valledor, Annabel F.|||0000-0003-4232-2633
  • Castrillo, Antonio|||0000-0002-2057-2159
  • Tabraue, Carlos|||0000-0001-9920-8116
The online version contains supplementary material available at 10.1007/s00018-024-05310-3.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Macrophage CD5L is a target for cancer immunotherapy

  • Sanchez-Moral, Lidia
  • Paul, Tony
  • Martori, Clara
  • Font-Díaz, Joan
  • Sanjurjo, Lucía
  • Aran, Gemma
  • Téllez, Érica
  • Blanco, Julià
  • Carrillo, Jorge
  • Ito, Masaoki
  • Tuttolomondo, Martina
  • Ditzel, Henrik J.
  • Fumagalli, Caterina
  • Tapia, Gustavo
  • Sidorova, Julia
  • Masnou, Helena
  • Fernández-Sanmartín, Marco-Antonio
  • Lozano, Juan-José
  • Vilaplana, Cristina
  • Rodriguez-Cortés, Alhelí
  • Armengol, Carolina
  • Valledor, Annabel F.
  • Kremer, Leonor
  • Sarrias, María Rosa
Reprogramming of immunosuppressive tumor-associated macrophages (TAMs) presents an attractive therapeutic strategy in cancer. The aim of this study was to explore the role of macrophage CD5L protein in TAM activity and assess its potential as a therapeutic target., This study was supported by the Instituto de Salud Carlos III (ISCIII), and ERDFs from the EU, ‘Una manera de hacer Europa’, grants PI19/00523, 2019 PROD 00118 AGAUR, CI20-00152 and CC22- 10181 Caixa Impulse to MRS, and from the Spanish Ministry of Science and Innovation grant PID2020-119875RB-I00 and PID2020-105404RB- I00 to AFV and LK, respectively. This research was also supported by the Consorcio Centro de Investigación Biomédica en Red (CIBERES and CIBEREHD). LSM, TP, JFD, and CM are supported by Juan de la Cierva (FJC2019-041213-I), PFIS (FI20/00115), FPI (PRE2018-085579), and Margarita Salas (MSGD2021-08) fellowships, respectively, all of which are programs run by the Spanish Government and NextGenerationEU, respectively. This study received funding from the EU’s Horizon 2020 Research and Development Program under grant agreement no 847762. The Innate Immunity lab and the UTE are accredited by the Catalan Agency for Management of University and Research Grants 2017-SGR- 490/2021-SGR-01186 and 2017-SGR-500/2021 SGR 00920, respectively. MRS, CV, and CA are researchers at IGTP, which is a member of the CERCA network of institutes supported by the Health Department of the Government of Catalonia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation

  • Hernández-Hernández, Irene
  • Rosa, Juan V. de la
  • Martín-Rodríguez, Patricia
  • Díaz-Sarmineto, Mercedes
  • Recio, Carlota
  • Guerra, Borja
  • Fernández-Pérez, Leandro
  • León, Theresa E.
  • Torres, Rosa
  • Font-Díaz, Joan
  • Roig, Ángela
  • Mora, Fernando de
  • Boscá, Lisardo
  • Díaz, Mario
  • Valledor, Annabel F.
  • Castrillo, Antonio
Lung type 2 pneumocytes (T2Ps) and alveolar macrophages (AMs) play crucial roles in the synthesis, recycling and catabolism of surfactant material, a lipid/protein fluid essential for respiratory function. The liver X receptors (LXR), LXRα and LXRβ, are transcription factors important for lipid metabolism and inflammation. While LXR activation exerts anti-inflammatory actions in lung injury caused by lipopolysaccharide (LPS) and other inflammatory stimuli, the full extent of the endogenous LXR transcriptional activity in pulmonary homeostasis is incompletely understood. Here, using mice lacking LXRα and LXRβ as experimental models, we describe how the loss of LXRs causes pulmonary lipidosis, pulmonary congestion, fibrosis and chronic inflammation due to defective de novo synthesis and recycling of surfactant material by T2Ps and defective phagocytosis and degradation of excess surfactant by AMs. LXR-deficient T2Ps display aberrant lamellar bodies and decreased expression of genes encoding for surfactant proteins and enzymes involved in cholesterol, fatty acids, and phospholipid metabolism. Moreover, LXR-deficient lungs accumulate foamy AMs with aberrant expression of cholesterol and phospholipid metabolism genes. Using a house dust mite aeroallergen-induced mouse model of asthma, we show that LXR-deficient mice exhibit a more pronounced airway reactivity to a methacholine challenge and greater pulmonary infiltration, indicating an altered physiology of LXR-deficient lungs. Moreover, pretreatment with LXR agonists ameliorated the airway reactivity in WT mice sensitized to house dust mite extracts, confirming that LXR plays an important role in lung physiology and suggesting that agonist pharmacology could be used to treat inflammatory lung diseases., This work was supported by grants from the Ministerio de Ciencia, Innovación y Fondo Europeo de Desarrollo Regional (FEDER), Agencia Estatal de Investigación grants PID2019-104284RB-I00, PID2022-137696OB-I00 funded by 10. 13039/501100011033 to AC and CT, grants PID2020-119875RB-I00 and SAF2017-89510-R to AFV and SAF2017-90604-REDT to the NuRCaMeIn network, grant PI18/01702 to FdM from the Instituto de Salud Carlos III and grant PROID2017010050 to CT from the Agencia Canaria de Investigación, Innovación y Sociedad de la Información (ACIISI). IHH and JFD received FPI predoctoral fellowships from the Spanish Ministerio de Ciencia, Innovación y Universidades (PRE2018-085579 to JFD and BES2009012191 to IHH)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Liver X Receptors and Inflammatory-Induced C/EBPβ Selectively Cooperate to Control CD38 Transcription

  • Glaria, Estibaliz
  • Rodríguez Martínez, Pol
  • Font-Díaz, Joan
  • Rosa, Juan V. de la
  • Castrillo, Antonio
  • Crawshaw, Dylan J.
  • Vidal Taboada, Jose Manuel
  • Saura, Josep
  • Matalonga, Jonathan
  • Chini, Eduardo N.
  • Caelles, Carme
  • Valledor, Annabel F.
[Introduction] Macrophages abundantly express liver X receptors (LXRs), which are ligand-dependent transcription factors and sensors of several cholesterol metabolites. In response to agonists, LXRs promote the expression of key lipid homeostasis regulators. Cross talk between LXRs and inflammatory signals exists in a cell type- and gene-specific manner. A common feature in the macrophage response to inflammatory mediators is the induction of CCAAT/enhancer-binding protein beta (C/EBPβ), a master transcriptional regulator and lineage-determining transcription factor in monocytes/macrophages., [Methods] Quantitative real-time PCR in control and C/EBPβ-deficient macrophages was used to explore the role of C/EBPβ in the cross talk between inflammatory mediators and the macrophage response to pharmacological LXR activation. The functional interaction between C/EBPβ and LXRs on selected genomic regions was further characterized by chromatin-immunoprecipitation (ChIP) and gene reporter studies., [Results] Whereas inflammatory signaling repressed several LXR-regulated genes involved in lipid metabolism, these effects were conserved after deletion of C/EBPβ. In contrast, inflammatory mediators and LXRs synergistically induced the expression of the multifunctional protein CD38 in a C/EBPβ-dependent manner. C/EBPβ and LXRs bound to several regions with enhancer activity upstream and within the mouse Cd38 gene and their functional cooperation in macrophages required intact binding sites for LXR and C/EBPβ., [Conclusion] This study reveals positive cross talk between C/EBPβ and LXRs during the macrophage inflammatory response, which selectively impacts CD38 expression., This work was supported by Grants SAF2017-89510-R and PID2020-119875RB-I00 to A.F.V. and C.C., PID2022-137696OB-I00 to A.C., and SAF2017-90604-REDT and SAF2015-71878-REDT to the NuRCaMeIn network, funded by MICIU/AEI/10.13039/501100011033 and by ERDF A way of making Europe; grants 201605.30 to A.F.V. and 201605.31 to C.C. funded by Fundació La Marató de TV3; grants PI14/302 to J.S., and PI19/0593 and PI23/0850 to J.M.V.T., funded by Instituto de Salud Carlos III and by ERDF/EU A way to make Europe; grant from Fundación Luzón (Programa de Ayudas para Proyectos de Investigación en ELA Unzué-Luzón 2024) to J.M.V.T.; grants 2021SGR01433 and 2021SGR01121 from AGAUR-Generalitat de Catalunya to A.F.V. and J.M.V.T., respectively; and the European Cooperation in Science and Technology (COST) Actions BM1404 Mye-EUNITER and CA20117 Mye-InfoBank. E.G. received a fellowship from the University of Barcelona (APIF). J.F.D. and J.M. received fellowships PRE2018-085579 and BES-2009-014828, respectively, funded by MICIU/AEI/10.13039/501100011033 and by FSE invests in your future., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Macrophage CD5L is a target for cancer immunotherapy

  • Sanchez-Moral, Lidia|||0000-0002-3795-8015
  • Paul, Tony|||0000-0003-4081-4343
  • Martori Muntsant, Clara|||0000-0002-7872-918X
  • Font-Díaz, Joan|||0000-0002-7686-2278
  • Sanjurjo, Lucía|||0000-0003-4006-8010
  • Aran, Gemma|||0000-0003-2005-8843
  • Téllez, Érica|||0000-0003-1034-6307
  • Blanco, Julià|||0000-0002-2225-0217
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Ito, Masaoki
  • Tuttolomondo, Martina
  • Ditzel, Henrik J.
  • Fumagalli, Caterina|||0000-0002-8614-7622
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Sidorova, Julia
  • Masnou, Helena|||0000-0003-0632-1393
  • Fernández-Sanmartín, Marco-Antonio
  • Lozano, Juan-José
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Rodriguez-Cortes, Alheli|||0000-0003-3617-0119
  • Armengol, Carolina|||0000-0002-4690-4027
  • Valledor, Annabel F.|||0000-0003-4232-2633
  • Kremer, Leonor|||0000-0002-2235-2010
  • Sarrias, Maria-Rosa|||0000-0001-6929-8069
Reprogramming of immunosuppressive tumor-associated macrophages (TAMs) presents an attractive therapeutic strategy in cancer. The aim of this study was to explore the role of macrophage CD5L protein in TAM activity and assess its potential as a therapeutic target. Monoclonal antibodies (mAbs) against recombinant CD5L were raised by subcutaneous immunization of BALB/c mice. Peripheral blood monocytes were isolated from healthy donors and stimulated with IFN/LPS, IL4, IL10, and conditioned medium (CM) from different cancer cell lines in the presence of anti-CD5L mAb or controls. Subsequently, phenotypic markers, including CD5L, were quantified by flow cytometry, IF and RT-qPCR. Macrophage CD5L protein expression was studied in 55 human papillary lung adenocarcinoma (PAC) samples by IHC and IF. Anti-CD5L mAb and isotype control were administered intraperitoneally into a syngeneic Lewis Lung Carcinoma mouse model and tumor growth was measured. Tumor microenvironment (TME) changes were determined by flow cytometry, IHC, IF, Luminex, RNAseq and RT-qPCR. Cancer cell lines CM induced an immunosuppressive phenotype (increase in CD163, CD206, MERTK, VEGF and CD5L) in cultured macrophages. Accordingly, high TAM expression of CD5L in PAC was associated with poor patient outcome (Log-rank (Mantel-Cox) test p = 0.02). We raised a new anti-CD5L mAb that blocked the immunosuppressive phenotype of macrophages in vitro. Its administration in vivo inhibited tumor progression of lung cancer by altering the intratumoral myeloid cell population profile and CD4 + T-cell exhaustion phenotype, thereby significantly modifying the TME and increasing the inflammatory milieu. CD5L protein plays a key function in modulating the activity of macrophages and their interactions within the TME, which supports its role as a therapeutic target in cancer immunotherapy. For a full list of funding bodies, please see the Acknowledgements.